Medical giant Amersham surges after £5bn takeover approach

Amersham, the medical technology company which grew out of the Government's atomic energy programme, has attracted a £5bn takeover approach.

The company was forced to admit yesterday that it is in early talks with a mystery bidder, sparking a day of intense speculation over the identity of the predator and sending Amersham shares up 16 per cent.

Analysts said a US firm was the most likely bidder, although Roche, the Swiss pharmaceuticals group, was also in the frame. The diverse nature of the Amersham business meant there was little agreement, even on which industry the approach may come from.

Amersham, led by Sir William Castell, the chief executive, confirmed the approach after takeover speculation pushed its shares up in early trading. The stock had been briefly suspended on the Oslo bourse, which said it was investigating insider trading.

The company said: "Amersham announces that it has received an approach which may or may not lead to an offer for the company as a whole. No agreement has been reached and a further announcement will be made as appropriate."

Amersham shares initially leapt by a quarter as hedge funds scrambled to close short positions, and the stock settled up 89.5p at 641p, valuing the company at £4.5bn.

Sir William has grown Amersham through a string of mergers to become the market leader in diagnostic imaging, making chemicals to enhance the images from x-rays and other body scans. This historic business grew out of a wartime research centre examining uses for radium ore, then used to produce luminous paint for ships and airplanes, and the company became, in 1983, the first to be privatised by Margaret Thatcher's government.

Amersham's newer businesses are protein separations, used in drug research and manufacture, and discovery systems, which makes laboratory equipment for medical research.

Potential bidders mentioned during yesterday's frenzied trading session - when eight times the usual number of Amersham shares were traded - included General Electric, the US conglomerate which already has a product development agreement with Amersham.

Max Herrmann, an analyst at ING Financial Markets, said the company would fit with Roche's diagnostics and drug research interests, and also with the diverse hospital supplies business being expanded by Johnson & Johnson, the US medical giant.

But others believed a perceived undervaluation of the smallest business - the troubled discovery systems division - might be behind the approach.

Mark Brewer of Dresdner Kleinwort Wasserstein said the discovery systems industry was in need of consolidation and this was the Amersham division with the most scope for improvement in margins.

He said: "Any bidder would ultimately break up the company, because none of the potential acquirers has a presence in all three of Amersham's markets. But I am not sure it has to be taken over to achieve value for shareholders, as a break-up is something the company itself could do."

Sir William, already one of the FTSE 100's best paid chief executives with a package worth £1.1m last year, would net £1.8m for his shares in the company if a bid went through at close to the current share price. The 56-year-old former Wellcome executive agreed last year to stay on "for the foreseeable future" as chief executive, prompting a potential successor, John Pafield, to leave the business. Friends say Sir William would like to go out on a deal.

Start your day with The Independent, sign up for daily news emails
Life and Style
A monstrous idea? Body transplants might no longer be science fiction
Science An Italian neurosurgeon believes so - and it's not quite as implausible as it sounds, says Steve Connor
Demba Ba (right) celebrates after Besiktas win on penalties
footballThere was no happy return to the Ataturk Stadium, where the Reds famously won Champions League
Arts and Entertainment
Natural beauty: Aidan Turner stars in the new series of Poldark
arts + ents
Mia Freedman, editorial director of the Mamamia website, reads out a tweet she was sent.
arts + ents
Arts and Entertainment
The write stuff: masters of story-telling James Joyce, left, and Thomas Hardy
arts + ents...begging to differ, John Walsh can't even begin to number the ways
Jose Mourinho on Sky Sports
footballEXCLUSIVE COLUMN Paul Scholes: It was not a leg-breaking tackle, as the Chelsea manager had claimed
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Telesales / Marketing Executive - B2B - OTE £25,000

£17000 - £25000 per annum: Recruitment Genius: An opportunity to join this new...

SThree: Trainee Recruitment Consultant

£18000 - £21000 per annum + OTE £45,000: SThree: SThree Group have been well e...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...

Recruitment Genius: Business Control Manager

£36000 - £44000 per annum: Recruitment Genius: Encouraging more businesses to ...

Day In a Page

HIV pill: Scientists hail discovery of 'game-changer' that cuts the risk of infection among gay men by 86%

Scientists hail daily pill that protects against HIV infection

Breakthrough in battle against global scourge – but will the NHS pay for it?
How we must adjust our lifestyles to nature: Welcome to the 'Anthropocene', the human epoch

Time to play God

Welcome to the 'Anthropocene', the human epoch where we may need to redefine nature itself
MacGyver returns, but with a difference: Handyman hero of classic 1980s TV series to be recast as a woman

MacGyver returns, but with a difference

Handyman hero of classic 1980s TV series to be recast as a woman
Tunnel renaissance: Why cities are hiding roads down in the ground

Tunnel renaissance

Why cities are hiding roads underground
'Backstreet Boys - Show 'Em What You're Made Of': An affectionate look at five middle-aged men

Boys to men

The Backstreet Boys might be middle-aged, married and have dodgy knees, but a heartfelt documentary reveals they’re not going gently into pop’s good night
Crufts 2015: Should foreign dogs be allowed to compete?

Crufts 2015

Should foreign dogs be allowed to compete?
10 best projectors

How to make your home cinema more cinematic: 10 best projectors

Want to recreate the big-screen experience in your sitting room? IndyBest sizes up gadgets to form your film-watching
Manchester City 1 Barcelona 2 player ratings: Luis Suarez? Lionel Messi? Joe Hart? Who was the star man?

Manchester City vs Barcelona player ratings

Luis Suarez? Lionel Messi? Joe Hart? Who was the star man at the Etihad?
Arsenal vs Monaco: Monaco - the making of Gunners' manager Arsene Wenger

Monaco: the making of Wenger

Jack Pitt-Brooke speaks to former players and learns the Frenchman’s man-management has always been one of his best skills
Cricket World Cup 2015: Chris Gayle - the West Indies' enigma lives up to his reputation

Chris Gayle: The West Indies' enigma

Some said the game's eternal rebel was washed up. As ever, he proved he writes the scripts by producing a blistering World Cup innings
In Ukraine a dark world of hybrid warfare and murky loyalties prevails

In Ukraine a dark world of hybrid warfare

This war in the shadows has been going on since the fall of Mr Yanukovych
'Birdman' and 'Bullets Over Broadway': Homage or plagiarism?

Homage or plagiarism?

'Birdman' shares much DNA with Woody Allen's 'Bullets Over Broadway'
Broadchurch ends as damp squib not even David Tennant can revive

A damp squib not even David Tennant can revive

Broadchurch, Series 2 finale, review
A Koi carp breeding pond, wall-mounted iPads and a bathroom with a 'wellness' shower: inside the mansion of Germany's 'Bishop of Bling'

Inside the mansion of Germany's 'Bishop of Bling'

A Koi carp breeding pond, wall-mounted iPads and a bathroom with a 'wellness' shower